Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation – Process development and manufacture of formulations using lipid nanoparticles Drug Delivery System technology – TOKYO, October 1, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) announces the conclusion of a manufacturing contract agreement with biotechnology company, VLP Therapeutics Japan LLC (Representative […]
Anti-influenza drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients TOKYO, September 23, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced today that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” (generic name: favipiravir, “Avigan”) conducted […]
Fujifilm Group Global Branding Campaign ‘NEVER STOP Healthcare 2020’ TV Commercials to be released in Japan and the US on August 27th FUJIFILM Holdings Corporation (President: Kenji Sukeno) is pleased to announce the launch of its ‘NEVER STOP Healthcare 2020’ global branding campaign, which aims to promote widespread awareness of its wide range of healthcare-related […]
Fujifilm Diosynth Biotechnologies Breaks Ground For Advanced Therapies Innovation Center in Texas COLLEGE STATION, Texas, August 19, 2020 – FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, held a virtual ground-breaking ceremony on August 19, 2020 to signal the start of its Advanced Therapies […]
FUJIFILM Diosynth Biotechnologies expands its partnership with Novavax to manufacture COVID-19 Vaccine Candidate at its Billingham site BILLINGHAM, UK, August 17,2020 — FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announce today that its site in Billingham, UK will manufacture antigen component of NVX-CoV2373, […]
FUJIFILM Wako Junyaku Co., Ltd. (Head Office: Chuo-ku, Osaka, President: Kazuo Shiraki) is a pretreatment reagent for PCR testing, “SARS-CoV-2 Lysis Buffer,” which uses saliva as a sample and enables rapid testing for new coronaviruses. “, and the new coronavirus gene detection kit “SARS-CoV-2 RT-qPCR Detection Kit Ver2” will be released in Japan from July […]
Latest stories from SonyAddict.com: Latest stories from 43addict.com: